menu
    • menu

    Company profile for 23andMe

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    23andMe, Inc. is the leading consumer genetics and research company. Founded in 2006, the mission of the company is to help people access, understand, and benefit from the human genome. The company was named by Glassdoor as one of the Best Places to Work in 2019, MIT Technology Review to its “50 Smartest Companies, 2017” list, and named one of Fast Company’s “25 Brands That Matter Now, 2017”. 23andMe has millions of ...
    23andMe, Inc. is the leading consumer genetics and research company. Founded in 2006, the mission of the company is to help people access, understand, and benefit from the human genome. The company was named by Glassdoor as one of the Best Places to Work in 2019, MIT Technology Review to its “50 Smartest Companies, 2017” list, and named one of Fast Company’s “25 Brands That Matter Now, 2017”. 23andMe has millions of customers worldwide, with more than 80 percent of customers consented to participate in research. 23andMe, Inc. is located in Sunnyvale, CA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    23andMeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    230 N Mathilda Ave, Sunnyvale, California 94086
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.23andme.com/en-int/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/23andme/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/23andMe/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genetic Variations Tied To Weight Loss, Side Effects Of GLP-1
    Genetic Variations Tied To Weight Loss, Side Effects Of GLP-1

    10 Apr 2026

    // PR NEWSWIRE

    https://www.reuters.com/business/healthcare-pharmaceuticals/health-rounds-genetic-variations-linked-weight-loss-side-effects-glp-1-drugs-2026-04-10/

    PR NEWSWIRE
    10 Apr 2026
    Share Share
    23andMe Study Identifies Genetic Predictors of GLP-1 Weight Loss
    23andMe Study Identifies Genetic Predictors of GLP-1 Weight Loss

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270332/0/en/New-23andMe-Research-Institute-Study-Identifies-Genetic-Predictors-for-GLP-1-Weight-Loss-Efficacy-and-Side-Effects.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    23andMe Unveils First-of-Its-Kind Ancestor DNA Discovery Tool
    23andMe Unveils First-of-Its-Kind Ancestor DNA Discovery Tool

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255434/0/en/23andMe-Introduces-Reconstructed-Ancestors-a-First-of-Its-Kind-DNA-Discovery-Tool.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    23AndMe Research Institute Appoints John Mcleod General Counsel
    23AndMe Research Institute Appoints John Mcleod General Counsel

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202303/0/en/23andMe-Research-Institute-Appoints-John-McLeod-General-Counsel-and-Chief-Risk-Officer.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    23AndMe Research Institute Helps Reconnect African Diaspora
    23AndMe Research Institute Helps Reconnect African Diaspora

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191824/0/en/23andMe-Research-Institute-Helps-Reconnect-African-Diaspora-to-Their-Roots-with-Release-of-250-High-Resolution-African-Genetic-Groups.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    23AndMe Research Institute Appoints Kael Reicin as CFO
    23AndMe Research Institute Appoints Kael Reicin as CFO

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181412/0/en/23andMe-Research-Institute-Appoints-Kael-Reicin-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search